Anti. 🐘<p>· Two studies on potential biomarkers for <a href="https://chaos.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MECFS</span></a> were published this month<br>· Stellate ganglion blocks, a procedure where an anesthetic is injected into nerves in the neck, may help reduce the severity of some symptoms of <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>LongCOVID</span></a> and ME<br>· An observational study is recruiting 40 people in Boston, Massachusetts to test for defects of air and blood flow in the lungs in people with Long COVID</p><p><a href="https://thesicktimes.org/2025/07/29/research-updates-july-29/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">thesicktimes.org/2025/07/29/re</span><span class="invisible">search-updates-july-29/</span></a></p><p><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ResearchUpdate</span></a> <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>COVID19</span></a></p>
#researchupdate
3 posts1 participant0 posts today
Replied in thread
self-harm
Replied in thread
· Three recent studies show the harmful effects of misdiagnosis for chronic diseases and conditions
· A new preprint shared in Research Square found a connection between post-exertional malaise (PEM) and microclots, or tiny blood clots that disrupt how oxygen moves through the body
· The Cohen Center for Recovery from Complex Chronic Illness (CoRE) at Mount Sinai in New York is now recruiting for their rapamycin clinical trial for #LongCOVID
https://thesicktimes.org/2025/06/10/research-updates-june-10/
The Sick Times - Chronicling the Long Covid crisis · Research updates, June 10 - The Sick TimesThree recent studies show the harmful effects of misdiagnosis for chronic diseases and conditions. The first, a meta-analysis in Psychological Bulletin of 151 studies encompassing 11 diseases (including Long COVID) and over 11,000 participants, found that medical gaslighting led to adverse impacts including diagnostic delay and emotional stress.
Replied in thread
· New NIH study found that around one in seven children under age six with a prior SARS-CoV-2 infection met the probable diagnostic criteria for #LongCOVID
· Pemivibart (Pemgarda), a monoclonal antibody that helps prevent COVID-19, was found to be “well tolerated” and effective in phase 3 clinical trial
· New preprint from researchers in the US & Canada used a model called “Mobius” to classify ME & Long COVID with 97% accuracy, using data from blood
https://thesicktimes.org/2025/06/03/research-updates-june-3/
The Sick Times - Chronicling the Long Covid crisis · Research updates, June 3 - The Sick TimesA new National Institutes of Health RECOVER program study in JAMA Pediatrics found that around one in seven children under age six with a prior SARS-CoV-2 infection met the probable diagnostic criteria for Long COVID. Studying over 1,000 infants, toddlers, and preschool-aged children, researchers revealed differences in how Long COVID presented between age groups.
Replied in thread
· A large study in Nature Genetics found a genetic risk factor for developing #LongCOVID
· Leading Long COVID and myalgic encephalomyelitis (ME) researchers have pushed back against an op-ed commissioned by the BMJ that spread false claims about #MECFS
· RECOVER-Treating Long COVID (TLC), the clinical trials initiative from the National Institutes of Health’s flagship Long COVID research program, shared updates about forthcoming trials
https://thesicktimes.org/2025/05/27/research-updates-may-27/
The Sick Times - Chronicling the Long Covid crisis · Research updates, May 27 - The Sick TimesA large study in Nature Genetics found a genetic risk factor for developing Long COVID. Researchers studied genetics data from 6,450 participants with Long COVID and over a million population controls across 16 countries, leading to the discovery that a variant near the FOXP4 gene increased the risk of the disease by about 60%.
Replied in thread
· #LongCOVID clinical trial assessing the monoclonal antibody AER002 found no difference between those who got the drug and placebo
· prospective study in Pediatric International found that, six months after SARS-C0V-2 infection, 23% of children had Long COVID symptoms
· Chinese study of five participants with Long COVID and myocarditis found severe damage in the mitochondria
https://thesicktimes.org/2025/05/20/research-updates-may-20/
The Sick Times - Chronicling the Long Covid crisis · Research updates, May 20 - The Sick TimesEarly results from a Long COVID clinical trial assessing the monoclonal antibody AER002 found no difference between those who got the drug and placebo. Researcher Michael Peluso revealed the results at the PolyBio Spring Symposium; he and his colleagues are still analyzing data and will publish a paper later.
Continued thread
· The Bateman Horne Center and Open Medicine Foundation recently released a highly anticipated ME and Long COVID clinical care guide.
· Researchers estimate a higher rate of new-onset diabetes after SARS-C0V-2 infection in a systematic review in Emerging Microbes and Infections
· A new preprint in Medxriv further demonstrates that Long COVID and ME are not deconditioning.
https://thesicktimes.org/2025/05/13/research-updates-may-13/
The Sick Times - Chronicling the Long Covid crisis · Research updates, May 13 - The Sick TimesThe Bateman Horne Center and Open Medicine Foundation recently released a highly anticipated ME and Long COVID clinical care guide. The 96-page guide has been praised by many in the community as a useful tool for clinicians, patients, and their families.
· Researchers state that post-vaccine syndrome is characterized by persistent immune dysregulation & issues with blood coagulation.
· A drug called dapagliflozin, used to treat Type 2 Diabetes, is being investigated for #LongCOVID in a clinical trial.
· A double-blind clinical trial is evaluating an experimental drug called REGN7544 for people with postural orthostatic tachycardia syndrome (POTS).
The Sick Times - Chronicling the Long Covid crisis · Research updates, May 6 - The Sick TimesA new preprint shared in Research Square analyzed the blood of people with post-vaccine syndrome (PVS). The small study evaluated 30 participants with PVS and compared them with controls using an advanced blood test technique. The researchers stated that post-vaccine syndrome is characterized by persistent immune dysregulation and issues with blood coagulation. “Our results highlight